Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-055
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.853
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
Deadline: September 29, 2027
Opportunity Number: PAR-25-020
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: September 29, 2027
Status: Posted
CFDA Numbers: 93.173
SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY
Deadline: September 29, 2029
Opportunity Number: DE-FOA-0003467
Agency: Advanced Research Projects Agency Energy
Open Date: October 2, 2024
Close Date: September 29, 2029
Status: Posted
CFDA Numbers: 81.135
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: August 18, 2027
Opportunity Number: PAR-24-293
Agency: National Institutes of Health
Open Date: October 1, 2024
Close Date: August 18, 2027
Status: Posted
CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866
Fundamental Research to Counter Weapons of Mass Destruction
Deadline: September 30, 2034
Opportunity Number: HDTRA1-25-S-0001
Agency: Defense Threat Reduction Agency
Open Date: October 1, 2024
Close Date: September 30, 2034
Status: Posted
CFDA Numbers: 12.351
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PA-25-080
Agency: National Institutes of Health
Open Date: October 1, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
Deadline: March 10, 2026
Opportunity Number: RFA-DA-26-009
Agency: National Institutes of Health
Open Date: September 30, 2024
Close Date: March 10, 2026
Status: Posted
CFDA Numbers: 93.279
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
Deadline: March 10, 2026
Opportunity Number: RFA-DA-26-010
Agency: National Institutes of Health
Open Date: September 30, 2024
Close Date: March 10, 2026
Status: Posted
CFDA Numbers: 93.279
Atmosphere Cluster
No deadline specified
Opportunity Number: PD-24-7790
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
Geospace Cluster
No deadline specified
Opportunity Number: PD-24-7789
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
Infrastructure Cluster
No deadline specified
Opportunity Number: PD-24-7791
Agency: U.S. National Science Foundation
Open Date: September 26, 2024
Status: Posted
CFDA Numbers: 47.050
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Deadline: June 15, 2027
Opportunity Number: RFA-MH-26-120
Agency: National Institutes of Health
Open Date: September 25, 2024
Close Date: June 15, 2027
Status: Posted
CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: August 18, 2026
Opportunity Number: PAR-25-051
Agency: National Institutes of Health
Open Date: September 25, 2024
Close Date: August 18, 2026
Status: Posted
CFDA Numbers: 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: January 20, 2026
Opportunity Number: RFA-NS-25-018
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: January 20, 2026
Status: Posted
CFDA Numbers: 93.173, 93.242, 93.853, 93.867, 93.279, 93.866, 93.273, 93.213, 93.865, 93.286
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
Deadline: January 20, 2026
Opportunity Number: RFA-NS-25-017
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: January 20, 2026
Status: Posted
CFDA Numbers: 93.865, 93.273, 93.213, 93.286, 93.853, 93.173, 93.866, 93.242, 93.279, 93.867
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
Deadline: September 25, 2027
Opportunity Number: PAR-24-301
Agency: National Institutes of Health
Open Date: September 24, 2024
Close Date: September 25, 2027
Status: Posted
CFDA Numbers: 93.865
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
Deadline: September 9, 2027
Opportunity Number: PAR-24-298
Agency: National Institutes of Health
Open Date: September 20, 2024
Close Date: September 9, 2027
Status: Posted
CFDA Numbers: 93.279
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Deadline: January 15, 2027
Opportunity Number: RFA-NS-25-023
Agency: National Institutes of Health
Open Date: September 18, 2024
Close Date: January 15, 2027
Status: Posted
CFDA Numbers: 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-24-297
Agency: National Institutes of Health
Open Date: September 17, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279
Multilateral Partnerships Leveraging Excellence
No deadline specified
Opportunity Number: PD-24-7298
Agency: U.S. National Science Foundation
Open Date: September 14, 2024
Status: Posted
CFDA Numbers: 47.079
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-275
Agency: National Institutes of Health
Open Date: September 11, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-043
Agency: National Institutes of Health
Open Date: September 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.393, 93.396
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-044
Agency: National Institutes of Health
Open Date: September 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393, 93.396, 93.399
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Deadline: September 28, 2027
Opportunity Number: PAR-24-272
Agency: National Institutes of Health
Open Date: September 3, 2024
Close Date: September 28, 2027
Status: Posted
CFDA Numbers: 93.350
NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)
Deadline: May 25, 2026
Opportunity Number: PAR-24-281
Agency: National Institutes of Health
Open Date: August 28, 2024
Close Date: May 25, 2026
Status: Posted
CFDA Numbers: 93.879, 93.313
